The Impact of Antimicrobial Resistance in Cystic Fibrosis

  30 March 2024

Antimicrobial resistance (AMR) is a global health issue that could become the leading cause of death in the future. It affects individuals with pre-existing conditions, such as neoplastic diseases, immunosuppressive therapy, and rare diseases like cystic fibrosis (CF). CF is a rare disease caused by a CFTR channel protein deficiency, causing recurrent pulmonary exacerbations. This review explores the relationship between AMR and climate dynamics, measuring methods, and the specific microbial communities in the CF airway. It emphasizes the urgent need for research in this field.

Further reading: J Clin Med
Author(s): Antonio Vitiello et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed